Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies W. Michael Flanagan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sarah Boyce - $3.54M of RNAM open-market activity in the last 12 months
- Teresa McCarthy - $1.84M of RNAM open-market activity in the last 12 months
- Troy Edward Wilson - $1.48M of RNAM open-market activity in the last 12 months
- Steven George Hughes - $619K of RNAM open-market activity in the last 12 months
- Eric Mosbrooker - $607K of RNAM open-market activity in the last 12 months
- Michael F. Maclean - $329K of RNAM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is W. Michael Flanagan?
W. Michael Flanagan is a corporate insider of Atrium Therapeutics, Inc. (RNA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did W. Michael Flanagan last file a Form 4?
The most recent primary Form 4 on record is dated 2 March 2026, one of 7 filings going back to 2024.
Has W. Michael Flanagan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($5.50M) across all tracked filings.
Where can I see all of W. Michael Flanagan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow W. Michael Flanagan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
